The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 02, 2016
Filed:
Dec. 30, 2013
Applicant:
Oribase Pharma, Montpellier, FR;
Inventors:
Gwénaël Cheve, Lunel, FR;
Bénédicte Dayde-Cazals, Montpellier, FR;
Bénédicte Fauvel, Montpellier, FR;
Cédric Bories, Montpellier, FR;
Abdelaziz Yasri, Castelnau le Lez, FR;
Assignee:
ORIBASE PHARMA, Montpellier, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/02 (2006.01); A61K 31/437 (2006.01); A61K 31/4353 (2006.01); C07D 471/04 (2006.01); C12Q 1/68 (2006.01); G01N 33/50 (2006.01); G01N 33/573 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/437 (2013.01); C12Q 1/6886 (2013.01); G01N 33/5023 (2013.01); G01N 33/573 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/912 (2013.01);
Abstract
The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.